Presidio FTW Stock Durable Goods Smart Money Active 20260420 FHB First Hawaiian posts narrow Q4 2025 EPS beat as shares climb 116 percent on strong revenue growth Regeneron Pharmaceuticals REGN Dupixent Secures FDA Approval as First Biologic for Pediatric Chronic Spontaneous Urticaria Expanding Blockbuster Drugs Addressable Market BKTI BK Tech reports 639 percent EPS surprise for Q4 2025 yet shares slip 23 percent in trading today